PDF(Pubmed)
Abstract：
Respiratory syncytial virus (RSV) is associated with considerable morbidity and mortality among older adults (aged ≥60 years) and adults with certain chronic conditions in the United States (US). Despite this burden, no previous studies have assessed the knowledge, attitudes, and perceptions (KAP) of RSV among these populations. This study evaluates RSV-related KAP among US adults at increased risk of severe RSV infection. A cross-sectional, web-based survey was administered from May to June 2022 to better understand respiratory infection- and RSV-related KAP among US adults who are at risk of severe RSV infection. The survey included ≥200 adults in each of 4 subgroups: adults aged 60-89 years, and adults aged 18-59 years with ≥1 chronic cardiovascular condition, chronic pulmonary condition, or diabetes mellitus. Survey responses were analyzed descriptively overall and by subgroup, with exploratory logistic regression modeling used to evaluate characteristics associated with RSV awareness and concern. Among the 827 survey respondents, only 43.3% had ever heard of RSV (n = 358/827). The study identified key knowledge gaps (e.g. bacterial vs. viral nature of respiratory infections, RSV seasonality, common RSV symptoms, extent to which RSV causes respiratory infections in specific patient populations). Although 33.7% of RSV-aware adults (n = 120/356) reported being worried/very worried about RSV, 67.3% (n = 241/358) rarely consider RSV as a potential cause of their cold/flu-like symptoms. Results from this study highlight important knowledge gaps related to RSV, perceived risk, and severity of RSV. Findings can be used to support the development of tailored education efforts to support RSV prevention.
What is the context? Respiratory syncytial virus (RSV) is a common cause of illness among older adults (60 years and older) and adults with certain chronic conditions in the United States (US), with some adults experiencing severe RSV outcomes such as hospitalization or death.Despite this considerable burden, the awareness of RSV among these at-risk populations has never been studied until now.What is new? We assessed RSV-related knowledge, attitudes, and perceptions among US adults at increased risk of severe RSV infection (adults aged 60–89 years and adults aged 18–59 years with ≥1 chronic cardiovascular condition, chronic pulmonary condition, or diabetes).Among older and at-risk adults, 43.3% had ever heard of RSV, with a lower awareness in the older adult subgroup.Among adults at increased risk of severe RSV who are aware of RSV, less than 35% consider themselves to be knowledgeable about RSV and 16–19% were unable to assess their perceived risk of contracting RSV or potential severity of RSV should they contract it.Knowledge gaps specific to RSV include the viral nature of RSV, its seasonality, symptoms, extent to which it causes respiratory infections in specific patient populations, the difficulty distinguishing RSV from other respiratory infections based on symptoms alone, and the limited testing for RSV in routine clinical practice.What is the impact? Two RSV vaccines were recently approved in the US and are recommended for the prevention of RSV among adults aged 60 years and older with shared clinical decision making.Results from this study reveal limited awareness of RSV among adults in the US at increased risk of severe RSV and knowledge gaps among those aware of RSV.These findings can be used by healthcare providers initiating shared clinical decision-making conversations with their patients aged 60 years and older who are eligible for RSV vaccination, as well as to tailor RSV disease awareness educational interventions to healthcare providers and patients.
What is the context? Respiratory syncytial virus (RSV) is a common cause of illness among older adults (60 years and older) and adults with certain chronic conditions in the United States (US), with some adults experiencing severe RSV outcomes such as hospitalization or death.Despite this considerable burden, the awareness of RSV among these at-risk populations has never been studied until now.What is new? We assessed RSV-related knowledge, attitudes, and perceptions among US adults at increased risk of severe RSV infection (adults aged 60–89 years and adults aged 18–59 years with ≥1 chronic cardiovascular condition, chronic pulmonary condition, or diabetes).Among older and at-risk adults, 43.3% had ever heard of RSV, with a lower awareness in the older adult subgroup.Among adults at increased risk of severe RSV who are aware of RSV, less than 35% consider themselves to be knowledgeable about RSV and 16–19% were unable to assess their perceived risk of contracting RSV or potential severity of RSV should they contract it.Knowledge gaps specific to RSV include the viral nature of RSV, its seasonality, symptoms, extent to which it causes respiratory infections in specific patient populations, the difficulty distinguishing RSV from other respiratory infections based on symptoms alone, and the limited testing for RSV in routine clinical practice.What is the impact? Two RSV vaccines were recently approved in the US and are recommended for the prevention of RSV among adults aged 60 years and older with shared clinical decision making.Results from this study reveal limited awareness of RSV among adults in the US at increased risk of severe RSV and knowledge gaps among those aware of RSV.These findings can be used by healthcare providers initiating shared clinical decision-making conversations with their patients aged 60 years and older who are eligible for RSV vaccination, as well as to tailor RSV disease awareness educational interventions to healthcare providers and patients.
摘要：
呼吸道合胞病毒（RSV）在美国（US）的老年人（年龄≥60岁）和患有某些慢性疾病的成年人中与相当高的发病率和死亡率有关。尽管有这样的负担,以前没有研究评估过这些知识，态度，以及这些人群对RSV的感知(KAP)。这项研究评估了严重RSV感染风险增加的美国成年人中与RSV相关的KAP。横截面，我们于2022年5月至6月进行了基于网络的调查,以更好地了解有严重RSV感染风险的美国成年人中呼吸道感染和RSV相关KAP.该调查包括4个亚组中≥200名成年人：60-89岁的成年人，和18-59岁的成年人，患有≥1项慢性心血管疾病，慢性肺部疾病，或糖尿病。调查反应进行了总体和亚组的描述性分析，探索性逻辑回归模型用于评估与RSV意识和关注相关的特征。在827名受访者中，只有43.3%的人听说过RSV(n=358/827)。这项研究确定了关键的知识差距(例如，细菌与呼吸道感染的病毒性质，RSV季节性，常见的RSV症状，RSV在特定患者人群中引起呼吸道感染的程度)。尽管有33.7％的RSV意识的成年人（n=120/356）表示担心/非常担心RSV，67.3％（n=241/358）很少认为RSV是感冒/流感样症状的潜在原因。这项研究的结果突出了与RSV相关的重要知识差距，感知风险，RSV的严重程度。研究结果可用于支持制定量身定制的教育工作，以支持RSV预防。
背景是什么？呼吸道合胞病毒（RSV）是美国老年人（60岁及以上）和患有某些慢性疾病的成年人的常见疾病原因，一些成年人经历严重的RSV结局，如住院或死亡。尽管有这么大的负担,这些高危人群对RSV的认知到目前为止从未被研究过.什么是新的？我们评估了RSV相关知识，态度，以及美国成年人对严重RSV感染风险增加的看法（60-89岁的成年人和18-59岁的患有≥1种慢性心血管疾病的成年人，慢性肺部疾病，或糖尿病）。在老年人和有风险的成年人中，43.3%的人听说过RSV,在老年人亚组中意识较低。在意识到RSV的严重RSV风险增加的成年人中，不到35%的人认为自己了解RSV,16-19%的人无法评估他们感知的RSV感染风险或RSV的潜在严重程度。特定于RSV的知识差距包括RSV的病毒性质，它的季节性，症状,它在特定患者人群中引起呼吸道感染的程度，仅根据症状很难区分RSV和其他呼吸道感染，以及在常规临床实践中对RSV的有限测试。有什么影响？美国最近批准了两种RSV疫苗，建议在60岁及以上的成年人中预防RSV，共同制定临床决策。这项研究的结果表明，美国成年人对RSV的认识有限，患有严重RSV的风险增加，并且意识到RSV的人之间存在知识差距。这些发现可供医疗保健提供者与符合RSV疫苗接种资格的60岁及以上的患者进行共享的临床决策对话。以及为医疗保健提供者和患者量身定制RSV疾病意识教育干预措施。
背景是什么？呼吸道合胞病毒（RSV）是美国老年人（60岁及以上）和患有某些慢性疾病的成年人的常见疾病原因，一些成年人经历严重的RSV结局，如住院或死亡。尽管有这么大的负担,这些高危人群对RSV的认知到目前为止从未被研究过.什么是新的？我们评估了RSV相关知识，态度，以及美国成年人对严重RSV感染风险增加的看法（60-89岁的成年人和18-59岁的患有≥1种慢性心血管疾病的成年人，慢性肺部疾病，或糖尿病）。在老年人和有风险的成年人中，43.3%的人听说过RSV,在老年人亚组中意识较低。在意识到RSV的严重RSV风险增加的成年人中，不到35%的人认为自己了解RSV,16-19%的人无法评估他们感知的RSV感染风险或RSV的潜在严重程度。特定于RSV的知识差距包括RSV的病毒性质，它的季节性，症状,它在特定患者人群中引起呼吸道感染的程度，仅根据症状很难区分RSV和其他呼吸道感染，以及在常规临床实践中对RSV的有限测试。有什么影响？美国最近批准了两种RSV疫苗，建议在60岁及以上的成年人中预防RSV，共同制定临床决策。这项研究的结果表明，美国成年人对RSV的认识有限，患有严重RSV的风险增加，并且意识到RSV的人之间存在知识差距。这些发现可供医疗保健提供者与符合RSV疫苗接种资格的60岁及以上的患者进行共享的临床决策对话。以及为医疗保健提供者和患者量身定制RSV疾病意识教育干预措施。
